(Q54749733)

3 June 2018

title

The role of matrix metalloproteinase-9 in dementia. (English)

1 reference

3 June 2018

0 references

Philippe Amouyel

4

0 references

author name string

Nicole Helbecque

series ordinal

1

1 reference

3 June 2018

Xavier Hermant

series ordinal

2

1 reference

3 June 2018

Dominique Cottel

series ordinal

3

1 reference

3 June 2018

language of work or name

English

0 references

publication date

1 October 2003

1 reference

3 June 2018

number of pages

3

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

3 June 2018

volume

350

1 reference

3 June 2018

issue

3

1 reference

3 June 2018

page(s)

181-183

1 reference

3 June 2018

Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Characterization of Neutral Proteinases from Alzheimer-Affected and Control Brain Specimens: Identification of Calcium-Dependent Metalloproteinases from the Hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Poststroke dementia: influence of hippocampal atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

β-Amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Incidence of dementia after ischemic stroke: results of a longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

The molecular and genetic basis of AD: the end of the beginning: the 2000 Wartenberg lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

1 reference

7 January 2021

Cardiovascular factors in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2803%2900905-4

7 January 2021

10.1016/S0304-3940(03)00905-4

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018